Galapagos | GLPG - Net Income

Stock Price
24.30
Daily Change
-0.06 -0.25%
Monthly
-4.33%
Yearly
2.71%
Q2 Forecast
23.85

Galapagos reported EUR782.15M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
argenx SE USD 532.95M 188.69M Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Genmab DKK 31M 370M Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 98.25M 28.72M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Incyte USD 299.28M 124.89M Dec/2025
Merck EUR 319M 583M Dec/2025
Neurocrine Biosciences USD 209.5M 102M Sep/2025
Novartis USD 2.41B 1.52B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
UCB EUR 1.08B 608M Dec/2025
Vertex Pharmaceuticals USD 1.19B 108.2M Dec/2025